ASPEN PHARMACARE HOLDINGS LIMITED - Notice of General Meeting - 15 August 2016

Notice of General Meeting - 15 August 2016

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number
1985/0002935/06 Share
code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


NOTICE OF GENERAL MEETING – 15 AUGUST 2016

Aspen is in the process of posting a notice to shareholders of a general meeting to be
held at Building Number 1, Healthcare Park, Woodlands Drive, Woodmead,
Johannesburg, Gauteng, on Monday, 15 August 2016 at 14:00.

This general meeting has been convened to:

1. Approve, as a special resolution, certain amendments to the Company’s
   Memorandum of Incorporation (“MOI”) relating to:

   1.1   fractional share entitlements – the proposed changes are aimed at aligning
         the MOI with recent changes of the JSE Listings Requirements; and

   1.2   the timing of proxy form lodgments – the proposed changes are aimed at
         aligning the MOI with recent case law on Section 58 of the Companies Act
         of 2008;

2. Re-elect, as an ordinary resolution, John Buchanan as a director who is retiring by
   rotation in terms of the memorandum of incorporation of the Company, who is
   eligible and offers himself for re-election. The board re-appointed Mr Buchanan as
   a director of the Company at its meeting held in September 2015 but this
   appointment was not confirmed by shareholders at the Company’s annual general
   meeting held on 7 December 2015 due to an oversight in the drafting of the notice
   to this meeting.

A copy of the notice of this general meeting is available from the Company Secretary,
Riaan Verster (rverster@aspenpharma.com).


Durban
15 July 2016

Sponsor:
Investec Bank Limited

Date: 15/07/2016 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.